Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Drops By 23.9%

Clearmind Medicine Inc. (NASDAQ:CMND) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 194,500 shares, a decline of 23.9% from the February 28th total of 255,600 shares. Based on an average daily volume of 953,700 shares, the days-to-cover ratio is currently 0.2 days. Currently, 6.5% of the company’s stock are short sold.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Clearmind Medicine stock. Citadel Advisors LLC boosted its holdings in shares of Clearmind Medicine Inc. (NASDAQ:CMND) by 115.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,158 shares of the company’s stock after purchasing an additional 20,429 shares during the quarter. Citadel Advisors LLC owned approximately 0.89% of Clearmind Medicine worth $53,000 at the end of the most recent quarter. 96.05% of the stock is owned by institutional investors and hedge funds.

Clearmind Medicine Trading Down 3.3 %

Shares of CMND opened at $1.04 on Tuesday. The stock has a market cap of $4.41 million, a PE ratio of -0.55 and a beta of 1.02. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.72. Clearmind Medicine has a 12 month low of $0.95 and a 12 month high of $2.30. The stock’s 50-day moving average is $1.26 and its two-hundred day moving average is $1.34.

Clearmind Medicine (NASDAQ:CMND) last issued its quarterly earnings data on Thursday, March 13th. The company reported ($0.24) EPS for the quarter.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.